SCHEMBL23374698

SCHEMBL23374698

CCN(C)Cc1ccc(F)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.47
HTT P42858 3/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
PYCR1 P32322 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MITF O75030 1/20 0.37
PARP1 P09874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23972532 0.81 HRH3 (0.50) RIPK1HTTALDH1A1CYP2C9
SCHEMBL3240218 0.79 HTT (0.44) RIPK1HTTALDH1A1KDM4EPYCR1
SCHEMBL23374701 0.79 RIPK1 (0.41) RIPK1HTTALDH1A1KDM4EPYCR1
SCHEMBL12763726 0.78 CHRNB2 (0.56) CHRNB2CHRNA4ALDH1A1KDM4EPYCR1
SCHEMBL171946 0.77 PYCR1 (0.60) RIPK1CHRNB2CHRNA4ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL27258921 0.75 PYCR1 (0.58) RIPK1CHRNB2CHRNA4ALDH1A1KDM4E
SCHEMBL12124994 0.74 TAAR1 (0.55) RIPK1CHRNB2CHRNA4ALDH1A1KDM4E
SCHEMBL25488451 0.74 RIPK1 (0.50) RIPK1HTTALDH1A1KDM4EMAOA
SCHEMBL27258858 0.74 HTT (0.46) RIPK1HTTALDH1A1MAOAMAOB
SCHEMBL126441 0.73 TRPA1 (0.46) RIPK1HTTALDH1A1SMN1; SMN2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548870-B2 Compounds useful as inhibitors of helios protein BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-10 US disclosed
WO-2021101919-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN BRISTOL-MYERS SQUIBB COMPANY (US) 2021-05-27 WO disclosed
US-20210147383-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN BRISTOL-MYERS SQUIBB COMPANY 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147383-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN IKZF2, RPL6, HNRNPR RIPK1 4233/4885HTT 2410/4885CHRNB2 4567/4885
US-11548870-B2 Compounds useful as inhibitors of helios protein IKZF2, RPL6, HNRNPR RIPK1 4233/4885HTT 2410/4885CHRNB2 4567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.